Skip to main content
OpenTrials

Clinical trial condition

Neuromuscular Junction Diseases

Explore clinical trials studying Neuromuscular Junction Diseases. Study availability and eligibility vary by location and protocol.

290 public trials 99 recruiting studies
Refine in advanced search Browse all conditions

Neuromuscular Junction Diseases trial results

Recruiting

A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

NCT04951622

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +10 more
Locations
  • Neuromuscular Research Center and Clinic Paradise Valley, Arizona, United States
  • HonorHealth Neurology Scottsdale, Arizona, United States
  • University of Southern California Los Angeles, California, United States
  • Stanford University Palo Alto, California, United States
View all 112 locations
View Trial Details
Recruiting

ADAPT Forward 2 - ISA2 - a Study to Evaluate the Safety, Tolerability and Efficacy of Empasiprubart IV Monotherapy in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis

NCT07673627

Conditions
AChR-Ab Seropositive Generalized Myasthenia Gravis, Autoimmune Diseases, Autoimmune Diseases of the Nervous System, +14 more
Locations
  • Visionary Investigators Network Miami, Florida, United States
  • Erlanger Health System Chattanooga, Tennessee, United States
View Trial Details
Recruiting

A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)

NCT06220201

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +13 more
Locations
  • Local Institution - 0011 Birmingham, Alabama, United States
  • University of California, Irvine Irvine, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
View all 35 locations
View Trial Details
Recruiting

Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)

NCT06463587

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Arizona Neuroscience Research, LLC Phoenix, Arizona, United States
  • Advanced Neurosciences Research LLC Longmont, Colorado, United States
  • University of Connecticut Health Center - Department of Medicine Farmington, Connecticut, United States
  • The George Washington University Medical Faculty Associates Foggy Bottom South Pavilion Washington D.C., District of Columbia, United States
View all 145 locations
View Trial Details
Recruiting

A Natural History Study in Participants With Congenital Myasthenic Syndromes (CMS) Due to Mutations in DOK7, MUSK, AGRN, or LRP4

NCT06078553

Conditions
Congenital Myasthenic Syndrome, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, +4 more
Locations
  • UC Davis Health - UC Davis Health Midtown Ambulatory Care Center Sacramento, California, United States
  • Ann and Robert H Lurie Children's Hospital of Chicago - Main Hospital Chicago, Illinois, United States
  • Hospital Sisters Health System (HSHS) - St Elizabeth's Hospital O'Fallon, Illinois, United States
  • Harvard Medical School - Boston Children's Hospital Boston, Massachusetts, United States
View all 32 locations
View Trial Details
Recruiting

A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis

NCT07501702

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations
  • Neurology Offices Boca Raton, Florida, United States
  • SFM Clinical Reseach, LLC Boca Raton, Florida, United States
  • Homestead Associates in Research Homestead, Florida, United States
  • UF Health Jacksonville Respiratory Therapy (PFT and DLCO) Jacksonville, Florida, United States
View all 24 locations
View Trial Details
Recruiting

A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders

NCT06680037

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, B-cell Mediated Autoimmune Disorders, +28 more
Locations
  • TG Therapeutics Investigational Trial Site La Jolla, California, United States
  • TG Therapeutics Investigational Trial Site Ann Arbor, Michigan, United States
  • TG Therapeutics Investigational Trial Site Omaha, Nebraska, United States
  • TG Therapeutics Investigational Trial Site New York, United States
View Trial Details

Related conditions